about
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to ...
Read More
29.66
0.06
(0.20%)
2.8M
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Alkermes PLC is on 13 Jan 2026 for the purpose of Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
Alkermes PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..